Locked Nucleic Acid (LNA) Drug Platform uses the specificity of “tiny” 8-mer LNA-based compounds to successfully inhibited miR-122 and dramatically reduce Hepatitis C virus in the liver and in bloodstream chronically infected with the Hepatitis C virus.
Keywords: 3D, Advertising / Marketing, Editorial, Patient Education, Biotechnology, Cell biology / Histology, Disease Management, Molecular Biology
© Linda Nye